I3A - Instituto de Investigación en Ingeniería de Aragón

Biomedical Engineering
Biomedical Engineering
Biomedical Engineering
Biomedical Engineering
Biomedical Engineering
Info
cerrarRadiotherapy treatment planning system
Biomedical Engineering
Biomedical Engineering
Info
cerrarBone modelling
Biomedical Engineering
Biomedical Engineering

The Biomedical Engineering Division is a clear example of the multidisciplinary approach of the I3A, as it brings together specialists in Biology, Medicine, Physics, Mathematics and Engineering who cooperate to develop technological applications to improve human health and quality of life. Current technologies for patient diagnosis, monitoring, therapy, surgery and solutions to help the disabled involve most fields of engineering. The specific research areas include:

  • Tissue engineering and biomaterials
  • Biological modeling and biomechanics
  • Imaging, signal and biomedical instruments
  • Healthcare and prevention technologies

 

Keywords

Mechanobiology, Biomaterials, tissue engineering, microfluidics, Bioreactors, diagnostic devices, cellular behavior modeling, microstructural behavior of biomaterials, heart electrophisiology, Telemedicine, Biomedical signals automatic coding methods, Biomedichal information transmission protocols, smart sensors, Computer visions algorithms for human detection, tracking and activity recognition, Prostheses design, Mesenchymal Stem Cells, Neurodegenerative diseases therapy, Prion Genetics and Genomics, Adapted human-machine interfaces, Indoor/outdoor location and guidance.


Key Projects

The CURABONE project aims to advance in the advancement and combination of different technologies, to achieve specific patient treatments in case of bone fractures.  In particular, it will focus...
The CURABONE project aims to advance in the advancement and combination of different technologies, to achieve specific patient treatments in case of bone fractures.  In particular, it will focus on cases of shoulder prostheses, knee prostheses, maxillofacial surgery and even tissue engineering. The ultimate goal is to help doctors make the best decisions for each patient and even planning their rehabilitation therapies. To achieve this goal, multiscale strategies will be developed that describe the problem from the biomechanics of the musculoskeletal system to the mechanobiological processes at the cellular level.
 
The CURABONE, ITN-EID project of Marie Curie actions financed by the European Commission (GA no 722535, H2020-MSCA-ITN-2016), is formed by a consortium of universities, companies and hospitals for the implementation of a European Industrial Doctorate (2017-2021). It is the first project of this type that is coordinated by the University of Zaragoza with a total budget of more than 1.2 million euros. 
Main reseacher: Esther Pueyo
 
MODELAGE proposes a multi-scale,multi-factorial research that is expected to make an important step in the characterization...
Main reseacher: Esther Pueyo
 
MODELAGE proposes a multi-scale,multi-factorial research that is expected to make an important step in the characterization of human heart aging at both the population and individual levels.
 
MODELAGE will work on an integrative methodological framework in which in silico modeling will be combined with in vitro cell and tissue analysis and in vivo electrocardiographic evaluation to investigate how cardiac aging manifests at a range of scales, from cell to body surface, and how electrical, structural and autonomic alterations contribute to such manifestations in humans.
 
By investigating the mechanisms underlying inter-individual differences in cardiac dynamics, MODELAGE will set links to arrhythmia susceptibility and will propose novel non-invasive markers to identify high-risk senescent individuals for which preventive anti-arrhythmic treatment
should be considered.
 
More info in:
PRIMAGE will address the study of two types of pediatric cancer that have high mortality and therapeutic complexity: neuroblastoma and diffuse trunk-brain glioma.  The consortium will exploit...
PRIMAGE will address the study of two types of pediatric cancer that have high mortality and therapeutic complexity: neuroblastoma and diffuse trunk-brain glioma.  The consortium will exploit the precision information provided by the medical imaging to establish the characteristics of the tumors, their prognosis and the expected response to the treatment through what is known as radiometry, image biomarkers and artificial intelligence. This knowledge will be transferable to all European hospitals and centers specialized in this type of childhood cancer. Due to the peculiarities of the computational approach to these two types of childhood tumors, research in this field will also be applicable in other types of tumors.
 
In this project 16 European institutions of high prestige participate, it is financed with more than 10 million euros through the European Horizon2020 program, it will last 4 years and is one of the biggest milestones in funding and scientific recognition achieved in Spain.
 
© 2019 Instituto Universitario de Investigación en Ingeniería de Aragón - Universidad de Zaragoza | Policy